Levofloxacin Sanovel

Levofloxacin, the active ingredient in Levofloxacin Sanovel, is a fluoroquinolone antibiotic presented as a strength/form for oral use. It treats a range of bacterial infections, including respiratory, urinary, and skin infections, primarily in adult patients.\n\nGNH India supplies Levofloxacin Sanovel as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levofloxacin is a broad‑spectrum antibacterial that targets susceptible bacteria in several organ systems.\n\nCommunity‑acquired respiratory tract infections: eradicates the causative pathogens, relieving cough and fever.\nUrinary tract infections: eliminates uropathogens, reducing dysuria and frequency.\nSkin and soft tissue infections: clears bacterial invasion, promoting wound healing.\nAcute bacterial sinusitis: resolves sinus inflammation by removing the infecting organisms.\nAcute bacterial prostatitis: treats prostatic infection, improving urinary symptoms and pain.

Levofloxacin may cause a variety of adverse reactions, ranging from mild to severe.\n\nCommon Side Effects:\n- Nausea\n- Diarrhea\n- Headache\n- Dizziness\n\nSerious or Rare Side Effects:\n- Tendon rupture or tendinitis\n- QT interval prolongation leading to arrhythmia\n- Severe allergic reactions such as anaphylaxis or Stevens‑Johnson syndrome

Levofloxacin requires careful assessment before and during therapy.\n\nAssess renal function: dose adjustment may be needed in impaired clearance.\nMonitor for tendon pain: discontinue if signs of tendinopathy appear.\nAvoid concomitant QT‑prolonging drugs: increased risk of cardiac arrhythmias.\nUse with caution in patients with a history of seizures or CNS disorders.\nReview all concurrent medications for potential interactions.\nStore at room temperature: keep in the original container, protect from moisture and direct sunlight.

Levofloxacin can interact with several medicines, altering its efficacy or safety.\n\nMajor Interactions (Avoid):\n- Antacids or supplements containing aluminum, magnesium, calcium, or iron: reduce levofloxacin absorption.\n- Non‑steroidal anti‑inflammatory drugs (NSAIDs): may diminish antibacterial activity.\n- Other fluoroquinolones: additive toxicity risk.\n- Drugs that prolong the QT interval (e.g., certain antiarrhythmics, macrolides): increase arrhythmia risk.\n\nModerate Interactions (Monitor Closely):\n- CYP1A2 inhibitors (e.g., caffeine, fluvoxamine): may raise levofloxacin plasma levels.\n- Warfarin: monitor INR closely as levofloxacin can enhance anticoagulant effect.